🔎 Trials Near Me

Beranda › Penyakit Paru › Texas

Uji klinis Penyakit Paru di Texas

22 studi untuk Penyakit Paru mencari peserta di lokasi di Texas.

Kota di Texas

Teks studi resmi (Bahasa Inggris)

Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen

  • Research Site, Amarillo
  • Research Site, Dallas
  • Research Site, El Paso
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05624450

A Study of COVID-19 Vaccine(s) in Children and Adults

  • Cedar Health Research, Dallas
  • Cedar Health Research, Euless
  • DM Clinical Research-Cyfair, Houston
  • dan 1 lainnya
Menerima pesertaFase 3Sukarelawan sehat diterima
Usia 5 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07798648

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

  • Zenos Clinical Research, Dallas
  • Southwest Family Medicine Associates, Dallas
  • Southwest Mind and Body Care, Dallas
  • dan 9 lainnya
Menerima pesertaFase 3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06679140

A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

  • Zenos Clinical Research, Dallas
  • Baylor Scott & White Health - Center for Advanced Heart and Lung Disease, Dallas
  • Baylor Scott & White Research Institute - Clinical Trials Office, Dallas
  • dan 8 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07013474

A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

  • Premier Pulmonary Critical Care and Sleep, Denison
  • Baylor College of Medicine Medical Center, Houston
  • Prime Clinical Research - Lewisville, Lewisville
Menerima pesertaFase 2
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07759245

American Lung Association (ALA) Lung Health Cohort

  • Baylor College of Medicine, Houston
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 25 hingga 35 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT04543461

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • MD Anderson, Houston
  • NEXT Dallas, Irving
  • NEXT Oncology San Antonio, San Antonio
  • dan 1 lainnya
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06128551

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma

  • South Texas Medical Research Institute, Inc., DBA TTS Research, Boerne
  • Horizon Clinical Research Group, Cypress
  • Alina Clinical Trials, LLC., Dallas
  • dan 2 lainnya
Menerima pesertaFase 2
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06977581

A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors

  • Site 1005, Houston
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT07407933

A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

  • GSK Investigational Site, Houston
  • GSK Investigational Site, Temple
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT06572384

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • USO - Texas Oncology, Austin
  • William Beaumont Army Medical Center, Fort Bliss
  • Houston Methodist Hospital, Houston
  • dan 3 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT06119581

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

  • Baylor College of Medicine, Houston
Menerima pesertaFase 2
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07059091

Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)

  • Premier Pulmonary Critical Care and Sleep Medicine, Denison
  • Renovatio Clinical, The Woodlands
  • Renovatio Clinical, Webster
Menerima pesertaFase 3
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07284602

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

  • Clinical Research Site, Houston
Menerima pesertaFase 2
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT07333183

A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.

  • University of Texas MD Anderson Cancer Center, Houston
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT05967689

A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma

  • Research Site, Lewisville
  • Research Site, San Antonio
Menerima pesertaFase 2
Usia 4 hingga 11 · Semua jenis kelamin · Diperbarui 27 Agu 2026 · NCT07525375

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

  • UT Southwestern Medical Center, Dallas
  • MD Anderson Cancer Center, Houston
Menerima pesertaFase 1/2
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 27 Mei 2026 · NCT03093116

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

  • Michael E. DeBakey VA Medical Center, Houston, TX, Houston
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 19 Feb 2026 · NCT02984761

A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

  • St. David's South Austin Medical Center, Austin
  • UT Southwestern Medical Center, Dallas
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Des 2025 · NCT06619561

Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis

  • University of Texas Southwestern Medical Center, Dallas
  • Metroplex Pulmonary and Sleep Center, McKinney
  • Research Centers of America, McKinney
Menerima pesertaFase 2
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 12 Nov 2025 · NCT05975983

Hyperinflation Respiratory Therapies in Cardiac Surgery Patients

  • UT Southwestern Clements University Hospital, Dallas
Menerima peserta
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 4 Nov 2025 · NCT04164173

Dari ClinicalTrials.gov, data diambil 3 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.